Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1251163 | 1.00 | ATM (0.42) | ATMMMP2ANPEPAGTR2 | |
| SCHEMBL21682443 | 1.00 | ATM (0.42) | ATMMMP2ANPEPAGTR2 | |
| SCHEMBL1251167 | 1.00 | ATM (0.42) | ATMMMP2ANPEPAGTR2 | |
| SCHEMBL1251161 | 1.00 | ATM (0.42) | ATMMMP2ANPEPAGTR2 | |
| SCHEMBL3846917 | 0.87 | MMP2 (0.41) | ATMMMP2ANPEP | |
| SCHEMBL3476452 | 0.86 | MMP2 (0.53) | MMP2ANPEP | |
| SCHEMBL1250595 | 0.85 | ATM (0.34) | ATMMMP2ANPEP | |
| SCHEMBL1250591 | 0.85 | ATM (0.34) | ATMMMP2ANPEP | |
| SCHEMBL1250589 | 0.85 | ATM (0.34) | ATMMMP2ANPEP | |
| SCHEMBL7946508 | 0.84 | MMP2 (0.37) | MMP2ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239782-A1 | SULFATE CRYSTALS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD OF PRODUCING SAME | LG CHEM, LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240239769-A1 | CO-CRYSTAL OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND VANILLIN AND METHOD FOR PREPARING SAME | LG CHEM, LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240239783-A1 | CRYSTAL FORM VII OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME | LG CHEM, LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240228473-A1 | CRYSTALLINE FORM V OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND METHOD FOR PREPARING SAME | LG CHEM, LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240217954-A1 | CRYSTAL FORM IV OF ORGANIC ACID SALTS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND PREPARATION METHOD THEREOF | LG CHEM, LTD. (KR) | 2024-07-04 | — | — | US | disclosed |
| US-20240190856-A1 | MELANOCORTIN-4 RECEPTOR AGONIST | LG CHEM, LTD. (KR) | 2024-06-13 | — | — | US | disclosed |
| CN-115160205-B | Method for preparing (S) -1- (tert-butoxycarbonyl) -2, 5-dihydro-1H-pyrrole-2-carboxylic acid and salt thereof | 上海皓鸿生物医药科技有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-20240182444-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-06 | — | — | US | disclosed |
| EP-4366831-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024086111-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20190330146-A1 | ALIPHATIC PROLINAMIDE DERIVATIVES | Orion Ophthalmology LLC (US) | 2019-10-31 | — | — | US | disclosed |
| US-20190322645-A1 | HETEROCYCLIC PROLINAMIDE DERIVATIVES | Orion Ophthalmology LLC (US) | 2019-10-24 | — | — | US | disclosed |
| US-20190202810-A1 | CARBOCYCLIC PROLINAMIDE DERIVATIVES | Orion Ophthalmology LLC (US) | 2019-07-04 | — | — | US | disclosed |
| EP-3472130-A1 | ALIPHATIC PROLINAMIDE DERIVATIVES | ORION OPTHALMOLOGY LLC (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-3472151-A1 | CARBOCYCLIC PROLINAMIDE DERIVATIVES | ORION OPTHALMOLOGY LLC (US) | 2019-04-24 | — | — | EP | disclosed |
| EP-3334710-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS | Alzheon, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2017222917-A1 | ALIPHATIC PROLINAMIDE DERIVATIVES | INCEPTION 4, INC. (US) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017222914-A1 | CARBOCYCLIC PROLINAMIDE DERIVATIVES | INCEPTION 4, INC. (US) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017027582-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS | ALZHEON, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
| WO-2004032834-A2 | THROMBIN INHIBITORS | MERCK & CO., INC. (US) | 2004-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217954-A1 | CRYSTAL FORM IV OF ORGANIC ACID SALTS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND PREPARATION METHOD THEREOF | MC4R, MC3R, MC5R | ATM 4495/4885MMP2 2668/4885ANPEP 4443/4885 |
| US-20240239782-A1 | SULFATE CRYSTALS OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD OF PRODUCING SAME | MC1R, MC5R, MC3R | ATM 4309/4885MMP2 4296/4885ANPEP 2576/4885 |
| US-20190202810-A1 | CARBOCYCLIC PROLINAMIDE DERIVATIVES | HTRA1, ADCYAP1R1, HTRA2 | ATM 4512/4885MMP2 92/4885ANPEP 238/4885 |
| US-20190322645-A1 | HETEROCYCLIC PROLINAMIDE DERIVATIVES | HTRA1, ALDH1A2, HTRA2 | ATM 4213/4885MMP2 145/4885ANPEP 279/4885 |
| US-20240182444-A1 | ANTI-VIRAL COMPOUNDS | EIF2AK2, ZC3HAV1, HAVCR2 | ATM 4728/4885MMP2 1455/4885ANPEP 539/4885 |
| US-20190330146-A1 | ALIPHATIC PROLINAMIDE DERIVATIVES | HTRA1, ALDH1A2, PREP | ATM 4108/4885MMP2 145/4885ANPEP 95/4885 |
| US-20240228473-A1 | CRYSTALLINE FORM V OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND METHOD FOR PREPARING SAME | MC5R, MC1R, MC3R | ATM 4481/4885MMP2 3969/4885ANPEP 2577/4885 |
| US-20240239769-A1 | CO-CRYSTAL OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND VANILLIN AND METHOD FOR PREPARING SAME | MC1R, MC5R, MC3R | ATM 2805/4885MMP2 4335/4885ANPEP 3162/4885 |
| US-20240190856-A1 | MELANOCORTIN-4 RECEPTOR AGONIST | MC4R, MC5R, MC3R | ATM 4112/4885MMP2 3417/4885ANPEP 1433/4885 |
| US-20240239783-A1 | CRYSTAL FORM VII OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME | MC5R, MC1R, MC3R | ATM 4499/4885MMP2 3818/4885ANPEP 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.